Stanford Cancer Center Emeryville is a clinical research site located in Emeryville, California, United States 94608.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
Stanford Cancer Center Emeryville has participated in 8 clinical trials with 7 currently active.
Therapeutic areas: Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, FIGO Stage III Ovarian Cancer 2014.
Sponsors: NRG Oncology, Canadian Cancer Trials Group, Alliance for Clinical Trials in Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Emeryville
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford Cancer Center Emeryville has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford Cancer Center Emeryville has 8 clinical trials on record, with 7 currently active. Their work covers Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, FIGO Stage III Ovarian Cancer 2014.
Stanford Cancer Center Emeryville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.